Miller-The ASAM Principles of Addiction Medicine, 7e

46

SECTION 1 • Basic Science and Core Concepts

75. Olds ME. Hypothalamic substrate for the positive reinforcing properties of morphine in the rat. Brain Res. 1979;168(2):351 ‐ 360. 76. Olds ME, Williams KN. Self-administration of D-Ala2-Met enkephalinamide at hypothalamic self-stimulation sites. Brain Res. 1980;194(1):155 ‐ 170. 77. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954;47(6):419 ‐ 427. 78. Bozarth MA, Wise RA. Localization of the reward-relevant opiate receptors. NIDA Res Monogr. 1982;41:158 ‐ 164. 79. Olds ME. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 1982;237(2):429 ‐ 440. 80. Goeders NE, Lane JD, Smith JE. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav. 1984;20(3):451 ‐ 455. 81. van der Kooy D, Mucha RF, O’Shaughnessy M, Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res . 1982;243(1):107-117. 82. Le Merrer J, Gavello-Baudy S, Galey D, Cazala P. Morphine self administration into the lateral septum depends on dopaminergic mechanisms: Evidence from pharmacology and Fos neuroimaging. Behav Brain Res. 2007;180(2):203 ‐ 217. 83. David V, Cazala P. Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice. Psychopharmacology. 2000;150(1):24 ‐ 34. 84. David V, Durkin TP, Cazala P. Differential effects of the dopamine D-2/D-3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. Psychopharmacology. 2002;160(3):307 ‐ 317. 85. Devine DP, Wise RA. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci. 1994;14(4):1978 ‐ 1984. 86. Welzl H, Kuhn G, Huston JP. Self-administration of small amounts of morphine through glass micropipettes into the ventral tegmental area of the rat. Neuropharmacology. 1989;28(10):1017 ‐ 1023. 87. Phillips AG, LePiane FG. Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav. 1980;12(6):965 ‐ 968. 88. Jenck F, Gratton A, Wise RA. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward. Brain Res. 1987;423(1-2):34 ‐ 38. 89. Broekkamp CL, Phillips AG. Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area. Pharmacol Biochem Behav. 1979;11(3):289 ‐ 295. 90. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav. 1984;20(6):917 ‐ 923. 91. Corrigall WA, Linseman MA. Conditioned place preference produced by intra-hippocampal morphine. Pharmacol Biochem Behav. 1988;30(3):787 ‐ 789. 92. Koob GF, Pettit HO, Ettenberg A, Bloom FE. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J Pharmacol Exp Ther. 1984;229(2):481 ‐ 486. 93. Britt MD, Wise RA. Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker. Brain Res. 1983;258(1):105 ‐ 108. 94. Corrigall WA, Vaccarino FJ. Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol Biochem Behav. 1988;30(2):443 ‐ 450. 95. Vaccarino FJ, Bloom FE, Koob GF. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology. 1985;86(1-2):37 ‐ 42. 96. Walker JR, Ahmed SH, Gracy KN, Koob GF. Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats. Brain Re . 2000; 854(1-2):85 ‐ 92. 97. Corrigall WA. Heroin self-administration: Effects of antagonist treatment in lateral hypothalamus. Pharmacol Biochemand Behav. 1987;27(4):693 ‐ 700.

98. Vaccarino FJ, Pettit HO, Bloom FE, Koob GF. Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat. Pharmacol Biochem Behav. 1985;23(3):495 ‐ 498. 99. Zito KA, Vickers G, Roberts DCS. Disruption of cocaine and heroin self administration following kainic acid lesions of the nucleus accumbens. Pharmacol Biochem Behav. 1985;23(6):1029 ‐ 1036. 100. Britt MD, Wise RA. Opiate rewarding action: Independence of the cells of the lateral hypothalamus. Brain Res. 1981;222(1):213 ‐ 217. 101. Alderson HL, Parkinson JA, Robbins TW, Everitt BJ. The effects of excitotoxic lesions of the nucleus accumbens core or shell regions on intravenous heroin self-administration in rats. Psychopharmacology. 2001;153(4):455 ‐ 463. 102. Hutcheson DM, Parkinson JA, Robbins TW, Everitt BJ. The effects of nucleus accumbens core and shell lesions on intravenous heroin self administration and the acquisition of drug-seeking behaviour under a second-order schedule of heroin reinforcement. Psychopharmacology. 2001;153(4):464 ‐ 472. 103. Martin TJ, Kim SA, Lyupina Y, Smith JE. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: Evidence from focal injections of beta-funaltrexamine. Psychopharmacology. 2002;161(2):152 ‐ 159. 104. Ettenberg A, Pettit HO, Bloom FE, Koob GF. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems. Psychopharmacology. 1982;78(3):204 ‐ 209. 105. Gerber GJ, Wise RA. Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: A variable dose paradigm. Pharmacol Biochem and Behav. 1989;32(2):527 ‐ 531. 106. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992;12(2):483 ‐ 488. 107. Hemby SE, Martin TJ, Co C, Dworkin SI, Smith JE. The effects of intravenous heroin administration on extracellular nucleus-accumbens dopamine concentrations as determined by in-vivo microdialysis. J Pharmacol Exp Ther. 1995;273(2):591 ‐ 598. 108. Lecca D, Valentini V, Cacciapaglia F, Acquas E, Di Chiara G. Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell versus core dopamine in the rat: a repeated sampling microdialysis study. Psychopharmacology. 2007;194(1):103 ‐ 116. 109. Bozarth MA, Wise RA. Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. NIDA Res Monogr. 1986;67:190 ‐ 196. 110. Pettit HO, Ettenberg A, Bloom FE, Koob GF. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self administration in rats. Psychopharmacology (Berl). 1984;84(2):167 ‐ 173. 111. Gerrits MAFM, VanRee JM. Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats. Brain Res. 1996;713(1-2):114 ‐ 124. 112. Herkenham M, Lynn AB, Little MD, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA. 1990;87(5):1932 ‐ 1936. 113. Abood ME, Martin BR. Neurobiology of marijuana abuse. Trends Pharmacol Sci. 1992;13(5):201 ‐ 206. 114. Onaivi ES. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology. 2006;54(4):231 ‐ 246. 115. Justinova Z, Tanda G, Redhi GH, Goldberg SR. Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl). 2003;169(2):135 ‐ 140. 116. Justinova Z, Solinas M, Tanda G, Redhi H, Goldberg SR. The endogenous cannabinoid anandamide and its synthetic analog R(+)- methanandamide are intravenously self-administered by squirrel monkeys. J Neurosci. 2005;25(23):5645 ‐ 5650. 117. Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W. Self administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience. 1998;85(2):327 ‐ 330. 118. Fattore L, Cossu G, Martellotta CM, Fratta W. Intravenous self administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl). 2001;156(4):410 ‐ 416.

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.